UCSF

ZINC21984084

Substance Information

In ZINC since Heavy atoms Benign functionality
December 11th, 2008 31 Yes

Other Names:

( -)-Ranolazine

(-)-Ranolazine

1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-

1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-

142387-99-3

95635-55-5

AC-1673

AC1L1M17

AC1Q5LYD

BRD-A97674275-001-01-9

BSPBio_002276

CHEMBL1404

CID56959

CPD000326795; Ranolazine dihydrochloride

CPD000326795; Ranolazine dihydrochloride; SAM001246534

CPD000326795; Ranolazine dihydrochloride; SAM001246534; ranolazine

CVT-303

CVT-303; RS-43285-003; RS-43285

D05700

DAP000875

DB00243

DIMETHYLPHENYLHYDROXYMETHOXYPHENOXYPROPYLPIPERAZINYLACETAMID

FDA

HMS1922F16

HMS2090L09

HMS2093D21

I01-2008

I06-0160

INN

KEG-1295

Latixa

LS-187267

MFCD00864690

MFCD03788770

MLS002154149

MolPort-003-666-653

N-(2,6-Dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxy-phenoxy)propyl)piperazin-1-yl)acetamide

N-(2,6-Dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide

N-(2,6-Dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide dihydrochloride

N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazinyl]acetamide dihydrochloride

N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide

N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide dihydrochloride

N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide

NA

NCGC00015897-05

NCGC00095177-01

NCGC00095177-02

NCGC00095177-03

RAN D

Ran4

Ranexa

Ranexa (TN)

Ranexa, Ranolazine

Ranolazine (FDA

Ranolazine (INN

Ranolazine (USAN/INN)

Ranolazine 2HCl

Ranolazine dihydrochloride

RS-43285

RS-43285-003

S1799_Selleck

SMR000857382

sodium 3,5-dicarboxybenzenesulfonate

SPECTRUM1505366

UNII-A6IEZ5M406

USAN); Ranolazine HCl (USAN)

USAN); Ranolazine Hydrochloride (USAN)

Download: MOL2 SDF SMILES Flexibase

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 1.92 6.74 -46.91 3 7 1 75 428.553 9
Mid Mid (pH 6-8) 1.92 4.54 -14.78 2 7 0 74 427.545 9
Mid Mid (pH 6-8) 1.92 6.89 -46.27 3 7 1 75 428.553 9

Vendor Notes

Note Type Comments Provided By
purity 9.500000000000000e+001 Enamine Building Blocks Enamine Building Blocks
Purity 95% Fluorochem
Purity 95+% Matrix Scientific
Therapy antianginal, antiischemic SMDC Pharmakon
PUBCHEM_PATENT_ID EP0407780A2; EP0407780B1; EP0465565A1; EP0465565B1; EP0697866B1; EP0714660A1; EP0719558A1; EP1015630A1; US5053419; US5472707; US5506229; US5506231; US5643915; US5795909; US5906988; US5968960; US6071743; WO1990011761A1; WO1992003137A1; WO1994026266A1; WO19 IBM Patent Data
Warnings IRRITANT Matrix Scientific
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP010131r; 2 hydrogen chloride NIH Clinical Collection via PubChem
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP010131r; SALT: 2 hydrogen chloride NIH Clinical Collection via PubChem
Purity ¡Ý99% APIChem

Activity (Go SEA)

Analogs ( Draw Identity 99% 90% 80% 70% )

No pre-computed analogs available. Try a structural similarity search.